O

Ossur hf
CSE:OSSR

Watchlist Manager
Ossur hf
CSE:OSSR
Watchlist
Price: 26.4 DKK -2.22% Market Closed
Market Cap: 11.3B DKK

Ossur hf
Additional Paid In Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Ossur hf
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
O
Ossur hf
CSE:OSSR
Additional Paid In Capital
$88.6m
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
-8%
Embla Medical hf
CSE:EMBLA
Additional Paid In Capital
$96.2m
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
-6%
No Stocks Found

Ossur hf
Glance View

Market Cap
11.3B DKK
Industry
Health Care

Ă–ssur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Ă–ssur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Ă–ssur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Ă–ssur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSR Intrinsic Value
Not Available

See Also

What is Ossur hf's Additional Paid In Capital?
Additional Paid In Capital
88.6m USD

Based on the financial report for Mar 31, 2024, Ossur hf's Additional Paid In Capital amounts to 88.6m USD.

What is Ossur hf's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-8%

Over the last year, the Additional Paid In Capital growth was 44%. The average annual Additional Paid In Capital growth rates for Ossur hf have been 8% over the past three years , and -8% over the past ten years .

Back to Top